Rank 71 • Biotech & Discovery
Proscia
Provides digital pathology software and AI applications that streamline laboratory workflows and improve diagnostic accuracy for cancer.
Visit website- Signal Score
- 84.6
- Total raised
- $82M
- Stage
- Series C
- Founded
- 2014
- Headquarters
- Philadelphia, USA
- Region
- North America
Their signal
Proscia's Concentriq platform is a leading enterprise choice for modern digital pathology labs, combining workflow management with diagnostic AI to accelerate research and clinical diagnostic speed.
Signal Score 84.6editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.